Insulin Glargine-Yfgn

Common brands: Insulin Glargine, Lantus, Basaglar Kwikpen, Basaglar Tempo Pen, Lantus Solostar

Top reporter: Biocon Biologics Inc.

Insulin Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Loop Diuretic [EPC]Corticosteroid [EPC]Platelet Aggregation Inhibitor [EPC]
21,112
Total Reports
10,197
Serious Reports
2,370
Death Reports
30
Reported Reactions
Death Report Ratio: High (11.23%)

Patient Demographics

Male
10,146
Female
9,149

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Insulin Glargine-Yfgn.

# Reaction Reports % of Total
1 HYPOGLYCAEMIA 1,577
7.4%
2 BLOOD GLUCOSE INCREASED 1,512
7.1%
3 ACUTE KIDNEY INJURY 969
4.6%
4 DYSPNOEA 956
4.5%
5 NAUSEA 910
4.3%
6 HYPERGLYCAEMIA 909
4.3%
7 DIARRHOEA 866
4.1%
8 DRUG INEFFECTIVE 866
4.1%
9 OFF LABEL USE 810
3.8%
10 VOMITING 801
3.8%
11 FATIGUE 778
3.7%
12 CONDITION AGGRAVATED 740
3.5%
13 DIZZINESS 653
3.1%
14 FALL 646
3.0%
15 ASTHENIA 641
3.0%
16 PNEUMONIA 583
2.7%
17 DRUG INTERACTION 582
2.7%
18 HYPOTENSION 561
2.6%
19 MALAISE 560
2.6%
20 PYREXIA 556
2.6%
21 PAIN IN EXTREMITY 537
2.5%
22 HEADACHE 502
2.4%
23 DIABETES MELLITUS INADEQUATE CONTROL 501
2.4%
24 ANAEMIA 497
2.3%
25 PAIN 488
2.3%
26 WEIGHT DECREASED 477
2.2%
27 DIABETIC KETOACIDOSIS 460
2.2%
28 DEHYDRATION 456
2.1%
29 LACTIC ACIDOSIS 454
2.1%
30 BLOOD GLUCOSE DECREASED 437
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.